Medtronic said about 1,000 people have sued the company over its bone morphogenetic protein-2 (BMP-2) product, Infuse, and that many more lawsuits may be coming.
In addition, several states now are looking into sales and marketing practices involving Infuse, which is used in spine surgery.
In a statement, company spokesperson Cindy Resman said the cases are in early procedural stages, and none have resulted in a finding of liability against Medtronic.
Some court rulings have led to dismissals and others have limited claims.
"Medtronic stands behind Infuse bone graft and will vigorously defend it in court," she said. To read the entire article click here.